|
|||||
|
|
Phase II study of a novel taxane (Cabazitaxel-XRP 6258) in previously treated advanced non-small cell lung cancer (NSCLC) patients |
|
| Authors: | Ankit Madan Benjamin S. Jones Rodolfo Bordoni Mansoor N. Saleh Mary S. Jerome Deborah K. Miley Bradford E. Jackson Francisco Robert |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |